Neothetics Announces Issuance by USPTO of Additional Patent Directed to LIPO-202 Lead Clinical Asset
October 06, 2015 08:00 ET
|
Neothetics, Inc.
SAN DIEGO, Oct. 6, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced the...
Neothetics Initiates Study to Evaluate the Safety of LIPO-202 for Body Contouring in Obese Subjects
September 30, 2015 08:00 ET
|
Neothetics, Inc.
SAN DIEGO, Sept. 30, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced the...
Neothetics Expands Its Board of Directors With Appointments of Jeffrey Nugent and Hani Zeini
September 28, 2015 08:00 ET
|
Neothetics, Inc.
SAN DIEGO, Sept. 28, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT) today announced that it has named Jeffrey Nugent and Hani Zeini to its Board of Directors.
Mr. Nugent is a respected...
Neothetics to Present at the OC Summit on Aesthetics and Dermatology
September 21, 2015 08:00 ET
|
Neothetics, Inc.
SAN DIEGO, Sept. 21, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced that...
Neothetics Announces Last Patient Enrolled in LIPO-202 Pivotal Phase 3 Clinical Trials for Reduction of Subcutaneous Abdominal Fat
September 08, 2015 08:00 ET
|
Neothetics, Inc.
SAN DIEGO, Sept. 8, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced...
Neothetics Reports Second Quarter 2015 Financial Results
August 13, 2015 08:00 ET
|
Neothetics, Inc.
SAN DIEGO, Aug. 13, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today reported...
Neothetics to Release Second Quarter 2015 Financial Results
August 06, 2015 08:00 ET
|
Neothetics, Inc.
SAN DIEGO, Aug. 6, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced that it...
Neothetics Announces Reaffirmation of Patents and Termination of Reexamination Challenge by United States Patent and Trademark Office
August 06, 2015 08:00 ET
|
Neothetics, Inc.
SAN DIEGO, Aug. 6, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (Nasdaq:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced the...
Neothetics Initiates Study to Evaluate the Post-Treatment Safety and Duration of Clinical Effect of LIPO-202 for Body Contouring
June 30, 2015 08:00 ET
|
Neothetics, Inc.
SAN DIEGO, June 30, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (Nasdaq:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced the...
Neothetics Reports First Quarter 2015 Financial Results
May 14, 2015 08:00 ET
|
Neothetics, Inc.
SAN DIEGO, May 14, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (Nasdaq:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today reported financial...